Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Anxiety Disorders HELP
Based on 23,526 articles published since 2009
||||

These are the 23526 published articles about Anxiety Disorders that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
201 Editorial [Psychological health in business]. 2012

Panter, Wolfgang. · ·Versicherungsmedizin · Pubmed #22808640.

ABSTRACT: -- No abstract --

202 Editorial Childhood anxiety: lessons learned. 2012

Rynn, Moira A / Vidair, Hilary B / Blackford, Jennifer Urbano. · ·Child Adolesc Psychiatr Clin N Am · Pubmed #22801002.

ABSTRACT: -- No abstract --

203 Editorial New neuropsychological data might help build a model of poor insight in obsessive-compulsive disorder: an editorial comment to Kashyap H, Kumar K, Kandavel T, Janardhan Reddy Yc. 'neuropsychological correlates of insight in obsessive-compulsive disorder' (1). 2012

Fontenelle, L F. · ·Acta Psychiatr Scand · Pubmed #22764751.

ABSTRACT: -- No abstract --

204 Editorial The complicated lessons of prohibition. 2012

Sajatovic, Martha. · ·Psychiatr Serv · Pubmed #22752029.

ABSTRACT: -- No abstract --

205 Editorial New trends in anxiety disorders. 2012

Nardi, Antonio E / Fontenelle, Leonardo F / Crippa, José Alexandre S. · ·Braz J Psychiatry · Pubmed #22729446.

ABSTRACT: -- No abstract --

206 Editorial Panic developments. 2012

Klein, Donald F. · ·Braz J Psychiatry · Pubmed #22729445.

ABSTRACT: -- No abstract --

207 Editorial Pregabalin in clinical psychiatry and addiction: pros and cons. 2012

Martinotti, Giovanni. · ·Expert Opin Investig Drugs · Pubmed #22725618.

ABSTRACT: Pregabalin acts as a presynaptic modulator of excitatory neurotransmitter release, binding to the α²-δ subunit protein of voltage-gated calcium channels. Pregabalin use is becoming widespread in the psychiatric scenario. Data are encouraging, with some good evidence for efficacy in anxious spectrum, benzodiazepine abuse/dependence, and alcoholism. The abuse potential, however, is an issue that should be taken into account, mostly in subjects at risk for developing substance/alcohol misuse.

208 Editorial The last therapeutic orphan: the pregnant woman. 2012

Wisner, Katherine L. · ·Am J Psychiatry · Pubmed #22684589.

ABSTRACT: -- No abstract --

209 Editorial Positivity impairments: pervasive and impairing (yet nonprominent?) features of social anxiety disorder. 2012

Weeks, Justin W / Heimberg, Richard G. · ·Cogn Behav Ther · Pubmed #22671568.

ABSTRACT: -- No abstract --

210 Editorial Rage takes center stage: focus on an underappreciated aspect of pediatric obsessive-compulsive disorder. 2012

Stewart, S Evelyn. · ·J Am Acad Child Adolesc Psychiatry · Pubmed #22632616.

ABSTRACT: -- No abstract --

211 Editorial Autoimmunity in psychiatry. 2012

Davison, Kenneth. · ·Br J Psychiatry · Pubmed #22550326.

ABSTRACT: Current knowledge of the role of autoimmunity in the pathogenesis of the main psychiatric disorders is briefly outlined. The significance of immunological effects on synaptic transmission and associated neuropsychiatric syndromes is emphasised. Clinical psychiatrists are encouraged to keep abreast of developments in this increasingly important area.

212 Editorial The RDoC project: a new paradigm for investigating the pathophysiology of anxiety. 2012

Simpson, Helen Blair. · ·Depress Anxiety · Pubmed #22511360.

ABSTRACT: -- No abstract --

213 Editorial [Emotions and lateral sclerosis]. 2012

Derouesné, Christian. · ·Geriatr Psychol Neuropsychiatr Vieil · Pubmed #22414399.

ABSTRACT: -- No abstract --

214 Editorial The importance of detecting anxiety in primary care. 2012

Kroenke, Kurt. · ·J Prim Health Care · Pubmed #22377543.

ABSTRACT: -- No abstract --

215 Editorial Mindfulness and psychiatry. 2012

Abbey, Susan E. · ·Can J Psychiatry · Pubmed #22340144.

ABSTRACT: -- No abstract --

216 Editorial Socioeconomic status and mental health: what is the causal relationship?: editorial comment to Kristian Tambs et al. 'Genetic and environmental contributions to the relationship between education and anxiety disorders. A twin study' (1). 2012

Sen, Srijan. · ·Acta Psychiatr Scand · Pubmed #22324730.

ABSTRACT: -- No abstract --

217 Editorial Cognitive bias modification: an intervention approach worth attending to. 2012

Macleod, Colin / Holmes, Emily A. · ·Am J Psychiatry · Pubmed #22318791.

ABSTRACT: -- No abstract --

218 Editorial A joint European and South African research network in anxiety disorders. 2012

Baldwin, David S / Stein, Dan J. · ·Hum Psychopharmacol · Pubmed #22278972.

ABSTRACT: -- No abstract --

219 Editorial [The most cited work in the 36th year of "Psychiatrischen Praxis." Congratulations!]. 2012

Riedel-Heller, Steffi G. · ·Psychiatr Prax · Pubmed #22234438.

ABSTRACT: -- No abstract --

220 Editorial The indolylglyoxylamide scaffold as an useful tool to obtain anxiolytic agents. 2012

Taliani, Sabrina / Da Settimo, Federico. · ·Curr Top Med Chem · Pubmed #22204480.

ABSTRACT: -- No abstract --

221 Editorial Benign paroxysmal positional vertigo: new opportunities but still old challenges. 2012

Kerber, Kevin A / Helmchen, Christoph. · ·Neurology · Pubmed #22170880.

ABSTRACT: -- No abstract --

222 Editorial Current status of knowledge on public-speaking anxiety. 2012

Pull, Charles B. · ·Curr Opin Psychiatry · Pubmed #22156935.

ABSTRACT: PURPOSE OF REVIEW: This review examines the current knowledge on public-speaking anxiety, that is, the fear of speaking in front of others. This article summarizes the findings from previous review articles and describes new research findings on basic science aspects, prevalence rates, classification, and treatment that have been published between August 2008 and August 2011. RECENT FINDINGS: Recent findings highlight the major aspects of psychological and physiological reactivity to public speaking in individuals who are afraid to speak in front of others, confirm high prevalence rates of the disorder, contribute to identifying the disorder as a possibly distinct subtype of social anxiety disorder (SAD), and give support to the efficacy of treatment programs using virtual reality exposure and Internet-based self-help. SUMMARY: Public-speaking anxiety is a highly prevalent disorder, leading to excessive psychological and physiological reactivity. It is present in a majority of individuals with SAD and there is substantial evidence that it may be a distinct subtype of SAD. It is amenable to treatment including, in particular, new technologies such as exposure to virtual environments and the use of cognitive-behavioral self-help programs delivered on the Internet.

223 Editorial Where is the room for improvement in the drug treatment of depression and anxiety? 2011

Baldwin, David S. · ·Hum Psychopharmacol · Pubmed #23055413.

ABSTRACT: -- No abstract --

224 Editorial "I can't stand needles!". 2011

Algase, Donna L. · ·Res Theory Nurs Pract · Pubmed #22216688.

ABSTRACT: -- No abstract --

225 Editorial A timely investment: coordinated care for depression and anxiety disorders. 2011

Sung, Sharon C / Rush, A John. · ·Ann Acad Med Singapore · Pubmed #22206051.

ABSTRACT: -- No abstract --

Back · Next